AMP 2026 has ended. This guide stays up as the record of who was there. Next: AMP 2027, Nov 9–13, 2027 in Baltimore

LGC at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

LGC brings 1 presentation to AMP 2026 in Seattle, and exhibits at Booth 1804, MR13. Its program centres on reference materials and best practice for tumor-agnostic measurable residual disease testing. The company supplies quality controls, diagnostic panels, sequencing controls and proficiency testing to clinical laboratories through its SeraCare business.

OrganizationAMP 2026 Attendance
LGC
Teddington, UK
Suppliers
Quality controls, reference materials, diagnostic panels, NGS controls and proficiency testing for clinical laboratories, through its SeraCare clinical diagnostics business.
Booth
Exhibiting at Booth 1804, MR13
Thu, Nov 1211:15am–7:00pmFri, Nov 139:00am–4:00pmSat, Nov 149:00am–1:30pm
Workshop
Wed, Nov 11
12:00pm–12:50pm
You’re So Naïve: Best Practices and Gold-Standard Reference Material for Tumor-Agnostic MRD Testing
Tumor-agnostic residual disease assays face validation hurdles, weighed against tumor-informed testing alongside reference materials.

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at LGC

Tell us what you sell and we’ll find the people at LGC most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction